SALL4 and acute myeloid leukemia: The data show that AML and AML+CYT treatments did not significantly affect the number of SALL4-stained cells/tubule, PLZF-stained cells/tubule or their expression levels at any of the examined time points compared to the control (Figure 4A–D).